Delivery Order SPE2DB22D2006-SPE2DB25FW4DR
- Not listed
- AmerisourceBergen Drug Corp has been awarded a $6,242.40 delivery order by the Defense Logistics Agency's Medical Supply Chain for the procurement of Infed 100 mg/2 mL vials. This firm fixed-price contract, issued on July 11, 2025, with an ultimate completion date of July 14, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed and delivered from the contractor's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,020.32 to AmerisourceBergen Drug Corp for the supply of Infed 100 mg/2 mL vials. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award represents a...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Infed 100 mg/2 ml vials. This competitively awarded, non-set-aside contract has a ceiling value of $9,315.83 and an ultimate completion date of April 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is...
- This delivery order, awarded August 4, 2025, to AmerisourceBergen Drug Corp represents a $10,075.02 firm fixed-price procurement of Infed 100 mg/2 mL vials for the Defense Department's Medical Supply Chain. The non-competitive delivery order will be performed in Conshohocken, Pennsylvania, with completion scheduled for August 5, 2025. As a child order under a larger contract vehicle, this award leverages AmerisourceBergen's established relationship with the Defense Logistics Agency for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,030.29 firm-fixed-price delivery order is for the supply of INFED 100 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has a performance period extending through June 23, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of INFED 100 MG/2 ML VIAL 2ML, a pharmaceutical product, with a ceiling value of $2,177.10 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA Troop...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of INFED 100 MG/2 ML VIAL 2ML pharmaceutical products. The total ceiling value of the contract is $8,055.27, and the ultimate completion date is April 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor for this award. The contract does not have a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Injectafer 750 mg/15 ml vials valued at $33,246.53 with a firm fixed price structure. This non-competitive, non-set-aside delivery order is set to conclude by September 9, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical...
- The Defense Logistics Agency awarded a $21,873.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price, competitively awarded contract is scheduled for completion by August 11, 2025, with performance based in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating AmerisourceBergen competed against other vendors to secure this pharmaceutical supply delivery. This delivery order...
- The Defense Logistics Agency awarded a $4,999.10 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product. This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and represents a non-competitive set-aside procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW4DRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Infed 100 mg/2 mL vials with a ceiling value of $1,922.68. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a non-competitive, non-set-aside procurement, reflecting AmerisourceBergen's established relationship with the federal medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, as a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal procurement requirements for medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/11/25 |